FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310600825> ?p ?o ?g. }

• W4310600825 endingPage "35" @default.
• W4310600825 startingPage "28" @default.
• W4310600825 abstract "<b><i>Introduction:</i></b> Osteoradionecrosis is a rare and debilitating risk of definitive chemoradiotherapy for head and neck squamous cell carcinoma. It is difficult to distinguish between osteoradionecrosis and recurrent or progressive disease, as clinical and radiologic features may be similar. Our aim was to compare the clinical presentation and radiologic features of osteonecrosis with those of recurrent or progressive cancer. <b><i>Methods:</i></b> We conducted a single-center case series of 19 patients with head and neck squamous cell carcinoma diagnosed between 2011 and 2019 who subsequently developed clinical and/or radiological suspicion of osteoradionecrosis. The population was a referred sample from head and neck cancer physicians at Northwell Health Cancer Institute. Clinician notes and imaging reports were reviewed to assign a final diagnosis of either cancer, osteonecrosis, or indeterminate. <b><i>Results:</i></b> No differences were found in the clinical presentation or radiologic features between groups. Median time between treatment and development of symptoms was longer in patients with a final diagnosis of osteoradionecrosis than recurrent or progressive disease (5 vs. 3 months), but this difference was not statistically significant. Radiation dose and type were not associated with diagnosis. Mean standard uptake value maximums on positron emission tomography/computed tomography were significantly higher in the cancer group (median 14.8 vs. 9.1, <i>p</i> &#x3c; 0.0152). At 1 year after first suspicion of osteoradionecrosis, 100% of osteoradionecrosis patients were alive, versus 28.6% of cancer patients. <b><i>Discussion/Conclusion:</i></b> There is significant overlap in clinical and radiologic features of osteoradionecrosis and cancer. Standard uptake maximums may be helpful in predicting diagnosis. Occurrence of symptoms within 6 months of completing chemoradiotherapy should raise the concern for malignancy." @default.
• W4310600825 created "2022-12-12" @default.
• W4310600825 creator A5008901024 @default.
• W4310600825 creator A5020651485 @default.
• W4310600825 creator A5026333806 @default.
• W4310600825 creator A5030166341 @default.
• W4310600825 creator A5057076345 @default.
• W4310600825 creator A5057647897 @default.
• W4310600825 creator A5070629404 @default.
• W4310600825 creator A5071977925 @default.
• W4310600825 creator A5075567509 @default.
• W4310600825 creator A5091561872 @default.
• W4310600825 date "2022-12-01" @default.
• W4310600825 modified "2023-09-26" @default.
• W4310600825 title "Osteoradionecrosis versus Cancer Recurrence: An Unresolved Clinical Dilemma" @default.
• W4310600825 doi "https://doi.org/10.1159/000527261" @default.
• W4310600825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36455537" @default.
• W4310600825 hasPublicationYear "2022" @default.
• W4310600825 type Work @default.
• W4310600825 citedByCount "0" @default.
• W4310600825 crossrefType "journal-article" @default.
• W4310600825 hasAuthorship W4310600825A5008901024 @default.
• W4310600825 hasAuthorship W4310600825A5020651485 @default.
• W4310600825 hasAuthorship W4310600825A5026333806 @default.
• W4310600825 hasAuthorship W4310600825A5030166341 @default.
• W4310600825 hasAuthorship W4310600825A5057076345 @default.
• W4310600825 hasAuthorship W4310600825A5057647897 @default.
• W4310600825 hasAuthorship W4310600825A5070629404 @default.
• W4310600825 hasAuthorship W4310600825A5071977925 @default.
• W4310600825 hasAuthorship W4310600825A5075567509 @default.
• W4310600825 hasAuthorship W4310600825A5091561872 @default.
• W4310600825 hasConcept C121608353 @default.
• W4310600825 hasConcept C126322002 @default.
• W4310600825 hasConcept C126838900 @default.
• W4310600825 hasConcept C2776530083 @default.
• W4310600825 hasConcept C2778424827 @default.
• W4310600825 hasConcept C2780037786 @default.
• W4310600825 hasConcept C2908647359 @default.
• W4310600825 hasConcept C2989005 @default.
• W4310600825 hasConcept C509974204 @default.
• W4310600825 hasConcept C71924100 @default.
• W4310600825 hasConcept C99454951 @default.
• W4310600825 hasConceptScore W4310600825C121608353 @default.
• W4310600825 hasConceptScore W4310600825C126322002 @default.
• W4310600825 hasConceptScore W4310600825C126838900 @default.
• W4310600825 hasConceptScore W4310600825C2776530083 @default.
• W4310600825 hasConceptScore W4310600825C2778424827 @default.
• W4310600825 hasConceptScore W4310600825C2780037786 @default.
• W4310600825 hasConceptScore W4310600825C2908647359 @default.
• W4310600825 hasConceptScore W4310600825C2989005 @default.
• W4310600825 hasConceptScore W4310600825C509974204 @default.
• W4310600825 hasConceptScore W4310600825C71924100 @default.
• W4310600825 hasConceptScore W4310600825C99454951 @default.
• W4310600825 hasIssue "1" @default.
• W4310600825 hasLocation W43106008251 @default.
• W4310600825 hasLocation W43106008252 @default.
• W4310600825 hasOpenAccess W4310600825 @default.
• W4310600825 hasPrimaryLocation W43106008251 @default.
• W4310600825 hasRelatedWork W1528324317 @default.
• W4310600825 hasRelatedWork W1995788949 @default.
• W4310600825 hasRelatedWork W2017704309 @default.
• W4310600825 hasRelatedWork W2122720675 @default.
• W4310600825 hasRelatedWork W2141123016 @default.
• W4310600825 hasRelatedWork W2555658172 @default.
• W4310600825 hasRelatedWork W2747560401 @default.
• W4310600825 hasRelatedWork W3011901168 @default.
• W4310600825 hasRelatedWork W4251015819 @default.
• W4310600825 hasRelatedWork W4316038857 @default.
• W4310600825 hasVolume "85" @default.
• W4310600825 isParatext "false" @default.
• W4310600825 isRetracted "false" @default.
• W4310600825 workType "article" @default.